Biotricity, Inc.
Biotricity, Inc. (BTCY) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
btcy · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$4.00
Consensus
$4.00
+3233.3% upside
Low
$4.00
Median: $4 · Last Close: $0.12
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.11 | ↓ 5.00% |
1-day model range: $0.11–$0.12. Peak: $0.12 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $0 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BTCY · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-11-20 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2023-07-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-02-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-07-15 | Maxim Group | Downgrade ↓ | Buy→Hold |
| 2022-07-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-03-07 | Lake Street | Maintains | Buy→Buy |
| 2021-11-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-07-01 | Northland Capital Markets | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on Biotricity, Inc. (BTCY) stock. Of the recent 8 rating actions, 0 were upgrades and 2 were downgrades. 4 analysts currently cover BTCY.
Analyst Recommendation Trends
BTCY analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$8M
↓ 37.9% YoY
Revenue Next Year
$10M
↑ 24.9% YoY
EPS This Year
$-3.46
EPS Next Year
$-2.28
↓ 34.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast BTCY EPS of $-3.46 for the current fiscal year, based on estimates from 1 analysts. The BTCY revenue forecast is $8M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BTCY stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BTCY price target is $4.00 (+3233.3% upside), with an analyst consensus of Buy.
The BTCY short-term stock prediction for tomorrow is $0.11 (-5.00%). The BTCY stock price prediction for 2027 estimates an average of $0. The BTCY stock prediction for 2030 projects a range of $0–$0.
Biotricity, Inc. trades on OTC under the ticker BTCY. The BTCY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
BTCY forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month BTCY price target is $4.00, with a high forecast of $4.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +3233.3% potential upside from the current price of $0.12.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.